- Prescribe by risk: the utility of a biomarker-based risk calculation in disease management to prevent heart diseaseMartin Root
BioSignia, Inc, Durham, North Carolina, USA
Dis Manag 8:106-13. 2005..In this simulation, identifying patients by heart disease risk level resulted in substantially fewer people being treated with fewer drugs and achieving a similar reduction in disease risk...
- Accuracy of prediction models in the context of disease managementGuizhou Hu
BioSignia Inc, 1822 E NC Highway 54, Suite 350, Durham, NC 27713, USA
Dis Manag 8:42-7. 2005..It also introduces a new accuracy parameter termed "cost concentration," which indicates the model accuracy more explicitly in the context of disease management...
- Assessing risk for coronary heart disease: beyond FraminghamFrederick R Cobb
Am Heart J 146:572-80. 2003